Dr. Mohile has disclosed that she is a consultant for Seattle Genetics, Inc. Dr. Gross has disclosed that he is an advisory board member for FAIR Health, Inc. Dr. Gajra has disclosed that he receives research support from Celgene Corporation and is on the advisory board for Bayer and Celgene Corporation. Dr. Hurria has disclosed that she receives research support from Celgene Corporation and GlaxoSmithKline, and is a consultant for GTx, Inc., Boehringer Ingelheim Pharmaceuticals, and Carevive Systems.
The remaining authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors. HJC is supported by NIH Grant 5U01AG034661.
This study was supported by K23 AG026749-01 (PI: Hurria) Paul Beeson Career Development Award in Aging Research), and American Society of Clinical Oncology—Association of Specialty Professors—Junior Development Award in Geriatric Oncology (PI: Hurria).
Abstract presentation: Owusu C, Tew W, Hardt M, et al. Anemia and functional disability in older adults with cancer. Presented at the 2012 ASCO Annual Meeting; June 1–5, 2012; Chicago, Illinois.
Nutritional Anaemias. Report of a WHO Scientific Group. Available at: http://apps.who.int/iris/bitstream/10665/40707/1/WHO_TRS_405.pdf. Accessed September 21 2015.
GuralnikJMEisenstaedtRSFerrucciL. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood2004;104:2263–2268.
LudwigHVan BelleSBarrett-LeeP. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer2004;40:2293–2306.
PenninxBWPahorMCesariM. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc2004;52:719–724.
PenninxBWPahorMWoodmanRC. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci2006;61:474–479.
AoeKHirakiAMaedaT. Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer. Intern Med2005;44:800–804.
BeerTMTangenCMBlandLB. Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894. J Urol2004;172(6 Pt 1):2213–2217.
LudwigHMuldurEEndlerGHublW. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol2013;24:1886–1892.
MancusoAMigliorinoMDe SantisS. Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol2006;17:146–150.
RepettoLFratinoLAudisioRA. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol2002;20:494–502.
HurriaATogawaKMohileSG. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol2011;29:3457–3465.
LoprinziCLLaurieJAWieandHS. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol1994;12:601–607.
KatzmanRBrownTFuldP. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry1983;140:734–739.
KarnofskyDBurchenalJ. The clinical evalaution of chemotherapeutic agents in cancer. In: MacleodCM ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1948:191–205.
FillenbaumGGSmyerMA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol1981;36:428–434.
WareJEJrSherbourneCD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care1992;30:473–483.
SeemanTEMerkinSSCrimminsEMKarlamanglaAS. Disability trends among older Americans: National Health and Nutrition Examination Surveys, 1988-1994 and 1999-2004. Am J Public Health2010;100:100–107.
SpillmanBC. Changes in elderly disability rates and the implications for health care utilization and cost. Milbank Q2004;82:157–194.
den ElzenWPWillemsJMWestendorpRG. Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ2009;181:151–157.
Barrett-LeePBokemeyerCGasconP. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. Oncologist2005;10:743–757.
CesariMPenninxBWPahorM. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci2004;59:242–248.
BrinkleyTELengXMillerME. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci2009;64:455–461.
VisserMPahorMTaaffeDR. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci2002;57:M326–332.
PayetteHRoubenoffRJacquesPF. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc2003;51:1237–1243.
CohenHJHarrisTPieperCF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med2003;114:180–187.
PenninxBWKritchevskySBNewmanAB. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc2004;52:1105–1113.
BastardJPMaachiMLagathuC. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw2006;17:4–12.
ChavesPHXueQLGuralnikJM. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?J Am Geriatr Soc2004;52:1811–1816.
HenkeMLaszigRRubeC. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet2003;362:1255–1260.
WrightJRUngYCJulianJA. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol2007;25:1027–1032.